The IMPA1 gene helps cells recycle inositol, a small molecule needed for many cell signals, especially in the brain. If it does not work properly, those signals can become less well controlled. Rare inherited variants in both copies of the IMPA1 gene can cause a condition that affects brain development, with intellectual disability and delays in speech or movement.
What is a gene?
Genes are sections of DNA that hold instructions cells use to make molecules or manage processes in the body. Some genes carry the instructions for producing proteins, the parts of cells that do much of the work. Other genes mainly regulate when certain processes happen, where they take place, and how strongly they are carried out. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To explore this subject in more detail, you can find more in LearnHub.
Overview
IMPA1Gene function
What if the gene works
The IMPA1 gene helps cells recycle inositol, a small molecule used to make cell signals. This supports communication between cells, especially in the brain, and helps normal signaling run smoothly.
Risk
What if the gene does not work
More disruptive variants in both copies of the IMPA1 gene can cause an inherited neurodevelopmental condition with developmental delay, speech problems, and intellectual disability. Effects can range in severity, and some people also develop behavior changes or cataracts.
Treatment
What does that mean for your treatment
At present, no treatment or management approach tailored to a pathogenic or loss-of-function variant in the IMPA1 gene is established in clinical guidelines. The IMPA1 gene is being studied in inositol signaling and as a possible lithium related drug target, but this has not changed routine treatment choices.
Conditions associated with IMPA1
Gene function
What if the gene works
Inside your cells, the IMPA1 gene helps recycle myo-inositol, a natural molecule used for cell messaging and membrane structure. This steady process supports routine communication within cells and helps keep key building materials available. Knowing what the IMPA1 gene does in the body helps show how small chemical steps support everyday cell function.
The IMPA1 gene helps cells recycle a used form of inositol back into myo-inositol. This keeps an important cell ingredient available for repeated use.
Cells use myo-inositol to make messenger molecules that help pass signals inside the cell. This lets cells respond in an organized way to everyday changes around them.
Myo-inositol also helps make certain fats that are part of cell membranes. Keeping these materials stocked supports routine cell activity across the body.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change a gene’s function more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
How variants in the IMPA1 gene affect protein function depends on the change: some missense variants alter the enzyme's shape or active site, while more disruptive variants can lower protein levels or leave little to no activity. These changes reduce a cell's ability to process key signaling molecules. Milder variants may leave partial activity, while severe loss of function variants can cause a larger cellular shortfall and, in people with two affected copies, are linked to more pronounced developmental effects.
How variants are linked to conditions
Pathogenic variants in the IMPA1 gene can cause a rare inherited condition marked by slower overall development, intellectual disability, and delayed speech. This IMPA1 gene condition is usually seen when a person inherits two altered copies, one from each parent. Some affected children also have learning difficulties or behavior differences, although features can vary from person to person.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply contribute to natural differences among people. For many genes, carrying a variant associated with a condition points to a possible link rather than a definite diagnosis, especially when several genes and environmental influences are involved. In some situations, though, one well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the IMPA1 gene. If an IMPA1 change is found, risk and day-to-day impact depend mostly on the specific genetic change and family history, and a doctor or genetic counselor can help explain what it may mean.
Inheritance of IMPA1 variants
For families looking into how IMPA1 gene variants are inherited, the well-established pattern is autosomal recessive. This means a child usually inherits one altered copy of the IMPA1 gene from each parent, and the parents are often healthy carriers. When both parents carry an IMPA1 variant, each pregnancy has a 25% chance of resulting in a child with the condition, a 50% chance of a child who is also a carrier, and a 25% chance of a child with neither altered copy.
What does my IMPA1 result mean for my family?
For families with an IMPA1-related condition, the pattern is usually recessive, which means parents are often healthy carriers and brothers or sisters could also be affected or be carriers. Other close relatives, such as siblings and adult family members planning children, may also want to learn whether they carry the same gene change. The family impact depends on the exact result and the condition linked to it.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the IMPA1 gene, doctors use genetic testing for IMPA1 variants on a blood or saliva sample. A lab reads the gene’s DNA code to see whether a variant is present, which can help confirm or rule out a condition linked to the IMPA1 gene.
When should I consider getting a genetic test?
Consider IMPA1 genetic testing if there is a family history of a rare inherited condition involving developmental delay or intellectual disability, especially when a relative already has a known IMPA1 variant. It may also be considered when a child has unexplained learning and developmental problems and the cause is still unclear.
A genetic result is only one part of your health story
A genetic finding may provide useful insight, but how much it reveals depends on the condition and the type of variant. Many factors, including lifestyle, environment, age, and medical history, influence how the body works over time. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help make individual experiences easier to understand.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in DNA can change how a drug is absorbed, broken down, transported, or how strongly it acts on its target in the body. This is common and helps explain why the same treatment works well for one person, seems less effective for another, or causes more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medications. By looking at relationships between genes and drugs, it helps explain why the same treatment can work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This understanding can support more informed, more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the IMPA1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication decisions, so questions about side effects, new symptoms, or whether a treatment is working are best discussed with your doctor or pharmacist.
History
Research on the IMPA1 gene grew out of efforts to understand how lithium works in the brain, especially during the 1980s and 1990s. Scientists first studied the enzyme linked to IMPA1 in animal tissue and cell models, then connected that work to the human gene as gene mapping and sequencing improved. From these first observations, research expanded steadily. Interest later widened when rare inherited variants in the IMPA1 gene were identified in families with intellectual disability, helping place the gene more clearly within clinical genetics. This history is mainly scientific rather than widely public, but it has been important in linking basic brain research with inherited neurodevelopmental conditions.